SMOFKABIVEN émuls perf 493ml sach 6 pce
7680606890095
CH-60689
B05BA10
07.01.2.
1 / 3
google
Details
- Product number
- 6068905
- CPT
- -
- Packaging group
- 6 x 493
- Unit
- ml
- Composition
- I) Glucoselösung 42 %: glucosum 62.5 g ut glucosum monohydricum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 149 ml. II) Aminosäurenlösung mit Elektrolyte: alaninum 3.5 g, argininum 3 g, glycinum 2.8 g, histidinum 0.8 g, isoleucinum 1.3 g, leucinum 1.9 g, lysinum anhydricum 1.7 g ut lysini acetas, methioninum 1.1 g, phenylalaninum 1.3 g, prolinum 2.8 g, serinum 1.6 g, taurinum 250 mg, threoninum 1.1 g, tryptophanum 0.5 g, tyrosinum 100 mg, valinum 1.6 g, calcii chloridum anhydricum 140 mg ut calcii chloridum dihydricum, natrii glycerophosphas 1.1 g, magnesii sulfas anhydricus 300 mg ut magnesii sulfas heptahydricus, kalii chloridum 1.1 g, natrii acetas 900 mg ut natrii acetas trihydricus, zinci sulfas anhydricus 3.3 mg ut zinci sulfas heptahydricus, acidum aceticum glaciale, aqua ad iniectabile q.s. ad solutionem pro 250 ml. III) Fettemulsion: sojae oleum raffinatum 5.6 g, triglycerida media 5.6 g, olivae oleum raffinatum 4.7 g, piscis oleum 2.8 g, int-rac-alpha-tocopherolum, phospholipida ex ovo purificata, glycerolum, natrii oleas, natrii hydroxidum, aqua ad iniectabile q.s. ad emulsionem pro 94 ml. . I) et II) et III) corresp.: aminoacida 25 g, nitrogenia 4 g, carbohydrata 62.5 g, materia crassa 19 g, natrium 20 mmol, kalium 15 mmol, magnesium 2.5 mmol, calcium 1.3 mmol, phosphas 6 mmol, zincum 0.02 mmol, sulfas 2.5 mmol, chloridum 18 mmol, acetas 52 mmol, in emulsione recenter mixta 493 ml. Corresp. 2300 kJ pro 493 ml.
Articles (1)
SmofKabiven, Infusionsemulsion 493 ml
Infusionsemulsion
6 x 493
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
I
|
62.5 G | Substance | Wirkstoff (Principe actif) |
|
III
|
5.6 G | Substance | Wirkstoff (Principe actif) |
|
II
|
3.5 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
25.0 G | Substance | Wirkstoff (Principe actif) |
|
III
|
5.6 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
4.0 G | Substance | Wirkstoff (Principe actif) |
|
I
|
- | Substance | WIZUS |
|
II
|
3.0 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
62.5 G | Substance | Wirkstoff (Principe actif) |
|
I
|
- | Substance | HNIDK |
|
II
|
2.8 G | Substance | Wirkstoff (Principe actif) |
|
III
|
4.7 G | Substance | Wirkstoff (Principe actif) |
|
III
|
2.8 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
19.0 G | Substance | Wirkstoff (Principe actif) |
|
II
|
0.8 G | Substance | Wirkstoff (Principe actif) |
|
I
|
- | Substance | HNIDK |
|
II
|
1.3 G | Substance | Wirkstoff (Principe actif) |
|
III
|
- | Substance | HNIDK |
|
123C
|
20.0 MMOL | Substance | Wirkstoff (Principe actif) |
|
123C
|
15.0 MMOL | Substance | Wirkstoff (Principe actif) |
|
III
|
- | Substance | HNIDK |
|
II
|
1.9 G | Substance | Wirkstoff (Principe actif) |
|
II
|
1.7 G | Substance | Wirkstoff (Principe actif) |
|
III
|
- | Substance | HNIDK |
|
123C
|
2.5 MMOL | Substance | Wirkstoff (Principe actif) |
|
III
|
- | Substance | HNIDK |
|
123C
|
1.3 MMOL | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | WIZUS |
|
III
|
- | Substance | HNIDK |
|
II
|
1.1 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
6.0 MMOL | Substance | Wirkstoff (Principe actif) |
|
III
|
- | Substance | HNIDK |
|
123C
|
0.02 MMOL | Substance | Wirkstoff (Principe actif) |
|
II
|
1.3 G | Substance | Wirkstoff (Principe actif) |
|
II
|
2.8 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
2.5 MMOL | Substance | Wirkstoff (Principe actif) |
|
II
|
1.6 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
18.0 MMOL | Substance | Wirkstoff (Principe actif) |
|
II
|
250.0 MG | Substance | Wirkstoff (Principe actif) |
|
123C
|
52.0 MMOL | Substance | Wirkstoff (Principe actif) |
|
II
|
1.1 G | Substance | Wirkstoff (Principe actif) |
|
II
|
0.5 G | Substance | Wirkstoff (Principe actif) |
|
II
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
1.6 G | Substance | Wirkstoff (Principe actif) |
|
II
|
140.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | WIZUS |
|
II
|
1.1 G | Substance | Wirkstoff (Principe actif) |
|
II
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | WIZUS |
|
II
|
1.1 G | Substance | Wirkstoff (Principe actif) |
|
II
|
900.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | WIZUS |
|
II
|
3.3 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | WIZUS |
|
II
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
Authorization holder
Fresenius Kabi (Schweiz) AG
6010 Kriens
Authorization information
- Swissmedic authorization number
- 60689
- Drug name
- SmofKabiven, Infusionsemulsion
- Galenic form
- EMUI
- ATC Code
- B05BA10
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 26/01/2011
- Authorization expiration date
- 31/12/9999
- IT number
- 07.01.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SMOFKABIVEN émuls perf 493ml sach 6 pce
- Description (DE)
- SMOFKABIVEN Inf Emuls 493ml Btl 6 Stk
- Market launch
- 30/08/2012
- Narcotic (BTM)
- No